Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$538M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 3 |
RTX Corp
RTX
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$332M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Huntsman Corp
HUN
$1.81B
| $11.6M | ﹤0.01% |
472,640
-334,694
| -41% | -$7.2M |
|
2027
Granite Construction
GVA
$5.4B
| $11.6M | ﹤0.01% |
230,893
+2,380
| +1% | +$127K |
|
2028
WaFd
WAFD
$2.8B
| $11.6M | ﹤0.01% |
349,899
-136,281
| -28% | -$4.57M |
|
2029
Sinclair Inc
SBGI
$1.02B
| $11.5M | ﹤0.01% |
285,154
-377,998
| -57% | -$13.9M |
|
2030
Healthcare Realty
HR
$7.02B
| $11.5M | ﹤0.01% |
365,861
+120,948
| +49% | +$3.67M |
|
|
FGL
2031
DELISTED
Fidelity & Guaranty Life
FGL
| $11.5M | ﹤0.01% |
413,419
-462,603
| -53% | -$11.9M |
|
|
JPMV
2032
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
| $11.5M | ﹤0.01% |
192,444
-1,757
| -0.9% | -$104K |
|
2033
AptarGroup
ATR
$8.66B
| $11.4M | ﹤0.01% |
148,665
+32,552
| +28% | +$2.43M |
|
|
KIO
2034
KKR Income Opportunities Fund
KIO
$455M
| $11.4M | ﹤0.01% |
670,718
+20,001
| +3% | +$333K |
|
2035
Vanguard Long-Term Bond ETF
BLV
$5.75B
| $11.4M | ﹤0.01% |
126,664
+5,972
| +5% | +$535K |
|
|
CAA
2036
DELISTED
CalAtlantic Group, Inc.
CAA
| $11.4M | ﹤0.01% |
304,081
+168,651
| +125% | +$5.96M |
|
2037
First Trust Germany AlphaDEX Fund
FGM
$98.6M
| $11.4M | ﹤0.01% |
288,086
+135,294
| +89% | +$5.16M |
|
2038
Schwab US Large-Cap Growth ETF
SCHG
$62.4B
| $11.4M | ﹤0.01% |
1,504,504
+79,224
| +6% | +$586K |
|
2039
John Wiley & Sons Class A
WLY
$2.74B
| $11.4M | ﹤0.01% |
211,134
-17,868
| -8% | -$971K |
|
2040
Azenta
AZTA
$1.38B
| $11.3M | ﹤0.01% |
506,372
+69,121
| +16% | +$1.37M |
|
|
CTLT
2041
DELISTED
CATALENT, INC.
CTLT
| $11.3M | ﹤0.01% |
399,863
-96,379
| -19% | -$2.7M |
|
2042
Nuveen Preferred & Income Opportunities Fund
JPC
$2.92B
| $11.3M | ﹤0.01% |
1,151,721
+43,293
| +4% | +$428K |
|
|
SWIR
2043
DELISTED
Sierra Wireless
SWIR
| $11.3M | ﹤0.01% |
424,447
+258,316
| +155% | +$5.95M |
|
|
GGN
2044
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$776M
| $11.3M | ﹤0.01% |
2,013,508
+527,070
| +35% | +$2.89M |
|
2045
Kulicke & Soffa
KLIC
$4.9B
| $11.2M | ﹤0.01% |
552,923
-75,654
| -12% | -$1.45M |
|
|
IBDJ
2046
DELISTED
iShares iBonds Dec 2017 Term Corporate ETF
IBDJ
| $11.2M | ﹤0.01% |
451,111
+61,313
| +16% | +$1.52M |
|
2047
Spire
SR
$4.72B
| $11.2M | ﹤0.01% |
165,893
-254,625
| -61% | -$16.6M |
|
|
GWR
2048
DELISTED
Genesee & Wyoming Inc.
GWR
| $11.2M | ﹤0.01% |
164,937
+13,839
| +9% | +$1M |
|
2049
iShares US Oil & Gas Exploration & Production ETF
IEO
$561M
| $11.2M | ﹤0.01% |
182,831
+10,008
| +6% | +$628K |
|
|
CACB
2050
DELISTED
Cascade Bancorp
CACB
| $11.2M | ﹤0.01% |
1,449,370
-46,792
| -3% | -$372K |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.